Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement

被引:0
|
作者
R. Resende Lima Oliveira de Brasil
D. Vieira Soares
L. Diniz Carneiro Spina
P. Marise Lobo
E. Maria Carvalho da Silva
V. Mansur Aleta
M. F. Miguens Castelar Pinheiro
F. L. Conceição
M. Vaisman
机构
[1] Federal University of Rio de Janeiro (UFRJ),Service of Endocrinology, Clementino Fraga Filho University Hospital, Medical School
[2] Previlab-Medical Services Ltda,undefined
[3] Medical Laboratory Sérgio Franco Diagnostic Medicine,undefined
关键词
Insulin resistance; blood pressure; ambulatory monitoring of blood pressure (AMBP); growth hormone; deficiency;
D O I
10.1007/BF03346297
中图分类号
学科分类号
摘要
The GH deficiency syndrome in adults is characterized by changes in body composition, metabolic, cardiovascular and psychological profile. Such alterations fit the metabolic syndrome. Changes of blood pressure (BP) levels related to the presence of insulin resistance (IR) may be present in the GH-deficient adult prior to or after therapy with recombinant GH (hGH). The purpose of the study was to assess the relationship between BP and IR in GH-deficient adults after 24 months of replacement with hGH. Thirteen GH-deficient adults were studied [7 men and 6 women, with an average age of 38.6±14.14 yr body mass index (BMI) 25.83±2.26 kg/m2]. The BP was assessed by means of ambulatory monitoring of BP (AMBP), prior to the treatment and 12 and 24 months after replacement with hGH. Glucose metabolism was assessed by the homeostatic model assessment (HOMA), during the same periods. The average dosage of hGH utilized was 0.67±0.15 mg/day. In the analysis of BP levels, we observed a decrease of the diurnal systolic BP (SBP) (p=0.043) and a reduction of the diurnal systolic (p=0.002) and diastolic pressure loads (p=0.038). During the night there were no changes in BP levels. We observed an increase in the percentage of patients with a non-physiological nocturnal fall (non dippers) after replacement with hGH (61.53%). The mean HOMA, insulin and glucose in the fasting state did not present any statistically significant changes. Although the patients within the non-dipper group had higher HOMA and insulin levels throughout the study, there were no changes in any of these parameters after GH replacement. All patients with HOMA >2.5 were within the non-dipper group, whereas all dippers had HOMA <2.5. In conclusion, 24 months of therapy with hGH do not seem to have affected glucose homeostasis, and since there is no relationship with the increase of the percentage of non-physiological nocturnal fall, we will need a longer observation time to discover the effects of this finding.
引用
收藏
页码:306 / 312
页数:6
相关论文
共 50 条
  • [21] Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects
    Woodmansee, Whitney W.
    Hartman, Mark L.
    Lamberts, Steven W. J.
    Zagar, Anthony J.
    Clemmons, David R.
    CLINICAL ENDOCRINOLOGY, 2010, 72 (01) : 59 - 69
  • [22] Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults
    Cook, DM
    Ludlam, WH
    Cook, MB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11): : 3956 - 3960
  • [23] The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
    Bengtsson, BÅ
    Abs, R
    Bennmarker, H
    Monson, JP
    Feldt-Rasmussen, U
    Hernberg-Ståhl, E
    Westberg, B
    Wilton, P
    Wüster, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11): : 3929 - 3935
  • [24] Differential effects of GH replacement on the components of the leptin system in GH-deficient individuals
    Randeva, HS
    Murray, RD
    Lewandowski, KC
    O'Callaghan, CJ
    Horn, R
    O'Hare, P
    Brabant, G
    Hillhouse, EW
    Shalet, SM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02): : 798 - 804
  • [25] GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset
    Columb, Breeda
    Smethurst, Linda E.
    Mukherjee, Annice
    Jostel, Andreas
    Shalet, Stephen M.
    Murray, Robert D.
    CLINICAL ENDOCRINOLOGY, 2009, 70 (02) : 281 - 286
  • [26] Fracture incidence in GH-deficient patients on complete hormone replacement including GH
    Holmer, Helene
    Svensson, Johan
    Rylander, Lars
    Johannsson, Gudmundur
    Rosen, Thord
    Bengtsson, Bengt-Ake
    Thoren, Marja
    Hoybye, Charlotte
    Degerblad, Marie
    Bramnert, Margareta
    Haegg, Erik
    Engstroem, Britt Eden
    Ekman, Bertil
    Thorngren, Karl-Goeran
    Hagmar, Lars
    Erfurth, Eva-Marie
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (12) : 1842 - 1850
  • [27] Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure
    Hoffman, DM
    Crampton, L
    Sernia, C
    Nguyen, TV
    Ho, KKY
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03): : 1123 - 1128
  • [28] Three-year experience with access to nationally funded growth hormone (GH) replacement for GH-deficient adults
    Holdaway, I. M.
    Hunt, P.
    Manning, P.
    Cutfield, W.
    Gamble, G.
    Ninow, N.
    Staples-Moon, D.
    Moodie, P.
    Metcalfe, S.
    CLINICAL ENDOCRINOLOGY, 2015, 83 (01) : 85 - 90
  • [29] Effect of growth hormone (GH) therapy on endothelial function in GH-deficient adults
    Pfeifer, M
    Poredos, P
    Zizek, B
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12): : 4923 - 4923
  • [30] Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients
    Norrelund, H
    Djurhuus, C
    Jorgensen, JOL
    Nielsen, S
    Nair, KS
    Schmitz, O
    Christiansen, JS
    Moller, N
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04): : E737 - E743